MP46-17 TRANEXAMIC ACID DOES NOT IMPACT HoLEP CLINICAL OUTCOMES

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy p=0.51) and prostate sizes (110.4 (63.4) vs 97.4 (66.2); p=0.13). Those who received TXA had lower rates of hypertension (47.5 vs 68.9%); p=0.05) including transfusion rate (Table 1). CONCLUSIONS: These findings support recent evidence suggesting that TXA has no impact on perioperative outcomes, such as blood loss, postoperative transfusion, prolonged length of stay, and Clavien II or greater complications. Its value should be considered in the dimensions of impact on surgical visibility and procedure length in future studies. Source of Funding: N/A © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e759 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Maria C. Velasquez More articles by this author Pablo A. Suarez More articles by this author Wilson Sui More articles by this author Heiko Yang More articles by this author Sultan Al Alzzawi More articles by this author Jorge Mena More articles by this author Justin Ahn More articles by this author Thomas Chi More articles by this author Expand All Advertisement PDF downloadLoading ...